AnaptysBio, Inc. (ANAB)

60.51 +7.68 (+14.54%) USD  |  NASDAQ  |  Mar 04, 16:00
59.34 -1.17 (-1.93%) After-Hours: 18:11
More

AnaptysBio Cash and Equivalents (Quarterly)

Cash and Equivalents (Quarterly) Chart

View Cash and Equivalents (Quarterly) for ANAB.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Equivalents (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Equivalents (Quarterly) Range, Past 5 Years

View Cash and Equivalents (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Equivalents (Quarterly) Benchmarks

View Cash and Equivalents (Quarterly) Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
Nektar Therapeutics Upgrade
Rigel Pharmaceuticals, Inc. Upgrade
AbbVie, Inc. Upgrade
Esperion Therapeutics, Inc. Upgrade